Natsar Pharmaceuticals
The startup develops targeted cancer therapies that focus on helicases, which are often dysregulated in various cancer types. By characterizing the cellular pathways essential for oncogenesis, the company aims to provide effective treatments for lung, brain, and breast cancers, as well as sarcoma and other diseases.
- Biotechnology
Updated 6 months ago
Funding
Raised to date
$4MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup develops targeted cancer therapies that focus on helicases, which are often dysregulated in various cancer types. By characterizing the cellular pathways essential for oncogenesis, the company aims to provide effective treatments for lung, brain, and breast cancers, as well as sarcoma and other diseases.